Lori Frederick

2.5k citations
22 papers · 1.8k · 1 hit paper · h-index 15

Impact in

  • Genetics top 1%
    • Glioma Diagnosis and Treatment
  • Oncology top 5%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research

Papers in

    • PI3K/AKT/mTOR signaling in cancer 4
    • RNA Research and Splicing 3
    • RNA modifications and cancer 3
    • Hedgehog Signaling Pathway Studies 2
    • Chronic Lymphocytic Leukemia Research 3
    • Glioma Diagnosis and Treatment 3
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 2

Lori Frederick

22 papers receiving 1.7k citations

Lori Frederick's Hit Papers

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. 2000 · 560 citations
5600+8+17Years since publication100200300400500

Peers

Lori Frederick
Comparison fields: 5 of 78
  • Genetics 640
  • Oncology 465
  • Cancer Research 250
  • Molecular Biology 1.1k
  • Pathology and Forensic Medicine 224
Replace Guido Reifenberger with:
Guido Reifenberger Germany
Nathalie Baeza France
G. Reifenberger Germany
Sergey Popov United Kingdom
Sandra H. Bigner United States
Jens Koopmann United States
Monica Hermanson Sweden
Aniello Cerrato Italy
Jana Karásková Canada
Márcia Regina Machein Germany
Lori Frederick relative to Guido Reifenberger Germany Guido Reifenberger's profile →
Citations per field
00.5×1.5×
Guido Reifenberger · 1×
Citations per year

Countries citing papers authored by Lori Frederick

Since Specialization
Citations

This map shows the geographic impact of Lori Frederick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Frederick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Frederick more than expected).

Fields of papers citing papers by Lori Frederick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Frederick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Frederick. The network helps show where Lori Frederick may publish in the future.

Co-authors

The 25 scholars most cited alongside Lori Frederick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lori Frederick Line = papers co-authored together Lori Frederick links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Hit paper breakdown →
2000560
2
Sporadic medulloblastomas contain PTCH mutations.
1997464
3
PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
1997170
4
Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
1999111
5 200881
6 200067
7 200758
8 199943
9 201834
10 201633
11 201432
12 199828
13 201523
14 199517
15 201115
16 199813
17
PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res, 57(23), 5254-5257
199810
18 20186
19 20145
20 20152

About Lori Frederick

Lori Frederick is a scholar working on Molecular Biology, Genetics, Hematology, Pathology and Forensic Medicine and Oncology, having authored 22 papers that have together received 1.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), RNA Research and Splicing (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), RNA modifications and cancer (3 papers), Glioma Diagnosis and Treatment (3 papers), Cancer Diagnosis and Treatment (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). The work is most often cited by research in Genetics (640 citations), Oncology (465 citations), Cancer Research (250 citations), Molecular Biology (1.1k citations) and Pathology and Forensic Medicine (224 citations). Lori Frederick has collaborated with scholars based in United States and India. Frequent co-authors include C. David James, Greg Eley, Xiao Yang Wang, Benjamin Alderete, R Jenkins, Daniel W. Fults, O. Raffel, Deanne Hebrink, Robert B. Jenkins and Alan P. Fields. Their work appears in journals such as American Journal of Hematology, American Journal of Clinical Pathology, Oncogene, Biochemical Society Transactions and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact